Pro Medicus (Australia) Today
| PME Stock | 227.64 5.89 2.66% |
Performance30 of 100
| Odds Of DistressLess than 1
|
Pro Medicus is selling for under 227.64 as of the 25th of November 2024; that is 2.66 percent increase since the beginning of the trading day. The stock's last reported lowest price was 223.37. Pro Medicus has a very small chance of experiencing financial distress in the next few years and had a strong performance during the last 90 days. Equity ratings for Pro Medicus are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Pro Medicus is entity of Australia. It is traded as Stock on AU exchange. The company has 104.5 M outstanding shares. More on Pro Medicus
Moving together with Pro Stock
Moving against Pro Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Pro Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pro Medicus' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pro Medicus or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, CoFounder | MD MBBS | ||||
| Business Concentration | Health Care Technology, Health Care Equipment & Services, Health Care, Health Care, Health Care Technology, Health Care Equipment & Services, Health Care (View all Sectors) | ||||
Pro Medicus' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Pro Medicus' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsPro Medicus can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Pro Medicus' financial leverage. It provides some insight into what part of Pro Medicus' total assets is financed by creditors.
| |||||
Pro Medicus (PME) is traded on Australian Securities Exchange in Australia and employs 10 people. Pro Medicus is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 23.79 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pro Medicus's market, we take the total number of its shares issued and multiply it by Pro Medicus's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pro Medicus operates under Health Care Technology sector and is part of Health Care industry. The entity has 104.5 M outstanding shares.
Pro Medicus generates positive cash flow from operations, but has no cash available
Check Pro Medicus Probability Of Bankruptcy
Ownership AllocationPro Medicus owns a total of 104.5 Million outstanding shares. Pro Medicus has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Pro Ownership Details
Pro Medicus Risk Profiles
Although Pro Medicus' alpha and beta are two of the key measurements used to evaluate Pro Medicus' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.34 | |||
| Semi Deviation | 1.26 | |||
| Standard Deviation | 1.74 | |||
| Variance | 3.04 |
Pro Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pro Medicus without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Pro Medicus Corporate Management
Elected by the shareholders, the Pro Medicus' board of directors comprises two types of representatives: Pro Medicus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pro. The board's role is to monitor Pro Medicus' management team and ensure that shareholders' interests are well served. Pro Medicus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pro Medicus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| BComm CPA | Chief Officer | Profile | |
| Danny CA | Financial Secretary | Profile | |
| Brad Levin | GM Marketing | Profile | |
| Sean Lambright | Global Inc | Profile |
Additional Tools for Pro Stock Analysis
When running Pro Medicus' price analysis, check to measure Pro Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Medicus is operating at the current time. Most of Pro Medicus' value examination focuses on studying past and present price action to predict the probability of Pro Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Medicus' price. Additionally, you may evaluate how the addition of Pro Medicus to your portfolios can decrease your overall portfolio volatility.